Progress of research on short-chain fatty acids, metabolites of gut microbiota, and acute ischemic stroke.

Clin Neurol Neurosurg

Department of Neurology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, China; College of Integration of Traditional Chinese and Western Medicine, Southwest Medical University, Luzhou, China; Institute of Integrated Chinese and Western Medicine, Southwest Medical University, Luzhou, China. Electronic address:

Published: January 2025

Acute ischemic stroke (AIS) significantly impacts the well-being and quality of life of individuals within our population. Short-chain fatty acids (SCFAs), metabolites produced by the intestinal microbiota, are integral to the bidirectional regulatory pathway linking the gut and the brain. SCFAs may significantly influence the risk, prognosis, recurrence, and management of complications associated with AIS. Potential mechanisms underlying these effects include the facilitation of brain-gut barrier repair, the mitigation of oxidative stress, the reduction of neuroinflammatory responses, and the inhibition of autophagy and apoptosis. Consequently, SCFAs hold promise as a prospective target for AIS intervention, with the potential to significantly impact AIS prevention and treatment strategies.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clineuro.2025.108725DOI Listing

Publication Analysis

Top Keywords

short-chain fatty
8
fatty acids
8
acute ischemic
8
ischemic stroke
8
progress short-chain
4
acids metabolites
4
metabolites gut
4
gut microbiota
4
microbiota acute
4
stroke acute
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!